LABORATORY NEWS
-
Roche Receives CE Mark For Blood Test To Identify Tuberculosis Infection
Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings.
- Tethis Expands Global Access To SmartBioSurface® Through New Channel Partners In Brazil, India, China And South Africa
- Quest Diagnostics Now The Largest Clinical Reference Lab To Extend Oncology Test Access Through OncoEMR MPI
- Ethos Laboratories Announces Exclusive U.S. Launch Of CNSDose™, Following Successful MolDX® Technical Assessment
- Kythera Labs Expands Partnership With Databricks Launching The Clinical Semantic Bridge MCP On Databricks Marketplace
ARCHIVED NEWSLETTER
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy